Thank you.

None discovered in our preclinical models.

None found in our preclinical models.

👍

👍

Thank you for your words.

👍

👍

👍

👍

Rapid one.

@@DrLiUBC even if this achieved it's gonaa be game changer it can replace daily 3 shots of rapid acting insulin to control PPBS

@@micro2159 yes

I don’t have any more info. It is a very experimental treatment involving regrowing your beta cells.

It is a cell therapy, not conventional drug pill.

Thank you for the encouragement.

🙂 This research is 100% supported by Canadian taxpayers.

Thank you for your encouragement. We are working tirelessly to achieve this goal.

Good job, god help you

@@LumnieHasollithank you!

Yes

Yes

Yes.

Thank you

Thank you

Hmm….

Everything that comes from humans is by money even they want to share oxygen leave it there is no way that you can involve in humans future. Even your drops might be killers who knows. Bring another change of insulin. We did not get any change from having pain and symptoms continue.

Thank you

It is expected to replace the bolus insulin.

Thank you for the encouragement!

​@@DrLiUBCcan I have your e-mail,please?

Thank you

If everything goes well, it is expected to be ready in 5 years.

Too late pl get this ready at the earliest

When we are ready for trials, we will announce broadly to recruit patients.

​@@DrLiUBC Dear doctor. Waiting for announcement.

Thanks for the comment

@@DrLiUBC Thank you Doctor Li for your contributions to science and the community.

@@Nadinetherescuehoundthank you. This research has been supported by public funding. You and all the tax payers have contributed to science and the community in one way or another.

what is crt been trying to research that treatment in China

@@michaelbritton2331 I believe CRT stands for cell replacement therapy. They try to regrow beta cells that produce insulin in the body of patients.

Thank you. This is a big motivation for us.

thank you

We are working towards starting the clinical trials in 2 years. If everything goes smoothly, the product is expected to be available in 5 years from now.

Thank you.

The results from small scale preclinical studies indicate that the absorption rate of the oral insulin drop is 10-30% of the injection. It requires clinical studies to accurately determine its dose and hypoglycaemia risk. The formulation does not provide sustained release effect for insulin, suggesting it will mainly address the bolus need. A sustained formulation is being developed.

​@@DrLiUBCdear doctor,when is it gonna be commercialized?can we have a timing please?

@@ilahaalakbarova7999 we are aiming to validate its efficacy and safety in human patients in 2 years. If all goes well, the product is expected to be ready in 5 years.

It is a long period 5 yrs . With in five yrsany can die and with in five yrs Our lord can come and may be the world ends. So chinese, you are bussiness people just you are making to gain more money not aiming to save people from their pain. So think kindly otherwise if you think to nake a bussiness it will destroy you back as a reward. Chinese are not liked by the Africans for they are greedy at money. So this shuld be changed but not only you including US.​@@DrLiUBC

i think oral insulin may lead to different strategy from what we learn in the med school ,it may not require bolus ,basal thing at all because if insulin come in form of consumable it can be easily designed the released mechanism.However,the most important concerning thing is how can you obtain stable absorbtion rate in patient because our body is different,if dr. can figure this out i believe it will gain the popularity in the patient and it can save patient both health and economic issue.Anyway ,Thank you for such a great effort to do an excellent research for humanity.

Thanks

Thanks.

Thanks

By AI under my instruction

:)

This is still under development.

😅

Thank you for your nice words.

😉

Thanks.

Thank you.

Thank you

Thank you for hosting me!

Thanks for the feedback. Although interesting, the approach would complicate the manufacturing process.